Ultrasound Training for Breast Cancer Diagnosis

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

Recruiting Observational Study
Breast Cancer Breast Cancer Female
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Female
Study type
Observational
Participants needed
900 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Other
Who this trial is looking for

This trial is looking for women aged 18 and older who have a suspicious breast mass seen on an ultrasound. By participating, radiologists in Nigeria will be trained on how to perform breast biopsies guided by ultrasound.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a female aged 18 or older.
  • I have a suspicious solid mass in my breast shown by ultrasound.

You may not be able to join if

  • I am not willing to sign consent.
  • I am under the age of 18.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies. Researchers will use mHealth devices to create a sustainable and practical way of training radiologists in Nigeria to perform and clinically implement US-guided breast biopsies into their practice.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18 and older female. * Breast ultrasound demonstrating a solid mass that is suspicious for cancer, which would typically undergo either a blind biopsy or surgical excision at the Nigerian hospital where the patient is seeking diagnosis. Exclusion Criteria: * Participants…
Contacts

Elizabeth Sutton, MD

646-888-5455

suttone@mskcc.org

CONTACT

Yolana Bryce, MD

212-639-6530

brycey@mskcc.org

CONTACT